
The healthcare debate in America often circles back to a fundamental question: should we move toward a single-payer system, or is our current mixed public-private model the better path forward? It’s a conversation that gets heated quickly, but when you strip away the politics and look at how different systems actually function around the world, some interesting patterns emerge.
What We Mean by Single-Payer
A single-payer healthcare system means that one entity—usually the government or a government-related organization—pays for all covered healthcare services. Doctors and hospitals can still be private (and usually are), but instead of dealing with dozens of different insurance companies, they bill one source. It’s a lot like Medicare, which is why proponents often call it “Medicare-for-all”.
The key thing to understand is that single-payer isn’t necessarily the same as socialized medicine. In Canada’s system, for instance, the government pays the bills, but doctors are largely in the private sector and hospitals are controlled by private boards or regional health authorities rather than being part of the national government. Compare that to the UK’s National Health Service, where many hospitals and clinics are government-owned and many doctors are government employees.
America’s Current Patchwork
The United States operates what might charitably be called a “creative” approach to healthcare—a complex mix of employer-sponsored private insurance, government programs like Medicare, Medicaid and the VA system, individual marketplace plans, and direct out-of-pocket payments. Government already pays roughly half of total US health spending, but benefits, cost-sharing, and networks vary widely between plans, with little overall coordination. In 2023, private health insurance spending accounted for 30 percent of total national health expenditures, Medicare covered 21 percent, and Medicaid covered 18 percent. Most of the remainder was either paid out of pocket by private citizens or was written off by providers as uncollectible.
Here’s where it gets expensive. U.S. health care spending grew 7.5 percent in 2023, reaching $4.9 trillion or $14,570 per person, accounting for 17.6 percent of the nation’s GDP, and national health spending for 2024 is expected to have exceeded $5.3 trillion or 18% of GDP, and health spending is expected to grow to 20.3 percent of GDP by 2033.
For a typical American family, the costs are real and rising. In 2024, the estimated cost of healthcare for a family of four in an employer-sponsored health plan was $32,066.
The European Landscape
Europe doesn’t have one healthcare model—it has several, and they’re all quite different from what we have in the States. Most of the 35 countries in the European Union have single-payer healthcare systems, but the details vary considerably.
Countries like the UK, Sweden, and Norway operate what are essentially single-payer systems where it is solely the government who pays for and provides healthcare services and directly owns most facilities and employs most clinical and related staff with funds from tax contributions. Then you have countries like Germany, and Belgium that use “sickness funds”—these are non-profit funds that don’t market, cherry pick patients, set premiums or rates paid to providers, determine benefits, earn profits or have investors. They’re quasi-public institutions, not private insurance companies like we know them in America. Some systems, such as the Netherlands or Switzerland, rely on mandatory individually purchased private insurance with tight regulation and subsidies, achieving universal coverage with a structured, competitive market.
The French System
France is particularly noted for a successful universal, government-run health insurance system usually described as a single-payer with supplements. All legal residents are automatically covered through the national health insurance program, which is funded by payroll taxes and general taxation.
Most physicians and hospitals are private or nonprofit, not government employees or facilities. Patients generally have free choice of doctors and specialists, though coordinating through a primary care physician improves access and reimbursement. The national insurer pays a large portion of medical costs (often 70–80%), while voluntary private supplemental insurance covers most remaining out-of-pocket expenses such as copays and deductibles.
France is known for spending significantly less per capita than the United States. Cost controls come from nationally negotiated fee schedules and drug pricing rather than limits on access.
What’s striking is that in 2019, US healthcare spending reached $11,072 per person—over double the average of $5,505 across wealthy European nations. Yet despite spending roughly twice as much per person, American health outcomes often lag behind.
The Outcomes Question
This is where the comparison gets uncomfortable for American exceptionalism. The U.S. has the lowest life expectancy at birth among comparable wealthy nations, the highest death rates for avoidable or treatable conditions, and the highest maternal and infant mortality.
In 2023, life expectancy in comparable countries was 82.5 years, which is 4.1 years longer than in the U.S. Japan manages this with healthcare spending at just $5,300 per capita, while Americans spend more than double that amount.
Now, it’s important to note that healthcare systems don’t operate in a vacuum. Life expectancy is influenced by many factors beyond medical care—diet, exercise, smoking, gun violence, drug overdoses, and social determinants of health all play roles. But when you’re spending twice as much and getting worse results, it suggests the system itself might be part of the problem.
Advantages of Single-Payer Systems
The case for single-payer rests on several compelling points. First, administrative simplicity translates to real cost savings. A study found that the administrative burden of health care in the United States was 27 percent of all national health expenditures, with the excess administrative cost of the private insurer system estimated at about $471 billion in 2012 compared to a single-payer system like Canada’s. That’s over $1 out of every $5 of total healthcare spending just going to paperwork, billing disputes, and insurance company profit and overhead before any patient receives care.
Universal coverage is another major advantage. In a properly functioning single-payer system, nobody goes bankrupt from medical bills, nobody delays care because they can’t afford it, and nobody loses coverage when they lose their job. The peace of mind that comes with knowing you’re covered regardless of employment status or pre-existing conditions is difficult to quantify but enormously valuable.
Single-payer systems also have significant negotiating power. When one entity is buying drugs and services for an entire nation, pharmaceutical companies and medical device manufacturers have much less leverage to charge whatever they want. This helps explain why prescription drug prices in other countries are often a fraction of prices in the U.S.
Disadvantages and Trade-offs
The critics of single-payer systems aren’t wrong about everything. Wait times are a genuine concern in some systems. When prices and overall budgets are tightly controlled, some countries experience longer waits for selected elective surgeries, imaging, or specialty visits, especially if investment lags demand.
In 2024, Canadian patients experienced a median wait time of 30 weeks between specialty referral and first treatment, up from 27.2 weeks in 2023, with rural areas facing even longer delays. For procedures like elective orthopedic surgery, patients wait an average of 39 weeks in Canada.
However, it’s crucial to understand that wait times are not a result of the single-payer system itself but of system management, as wait times vary significantly across different single-payer and social insurance systems. Many European countries with universal coverage don’t experience the same wait time issues that plague Canada.
The transition costs are also substantial. Moving from our current system to single-payer would disrupt a massive industry. Over fifteen percent of our economy is related to health care, with half spent by the private sector. Around 160 million Americans currently have insurance through their employers, and transitioning all of them to a government-run plan would be an enormous administrative and political challenge.
A large national payer can be slower to change benefit designs or adopt new payment models; shifting political majorities can affect funding levels and benefit generosity.
Taxes would need to increase significantly to fund such a system, though proponents argue this would be offset by the elimination of insurance premiums, deductibles, and co-pays. It’s essentially a question of whether you’d rather pay through taxes or through premiums—the money has to come from somewhere.
Advantages of America’s Mixed System
Our current system does have some genuine strengths. Innovation thrives in the American healthcare market. The profit motive, for all its flaws, does drive pharmaceutical research and medical device development. American medical schools and research institutions lead the world in many areas of medicine. Academic medical centers and specialty hospitals deliver advanced procedures and complex care that attract patients internationally.
The system also offers more choice for those who can afford it. If you have good insurance, you typically face shorter wait times for elective procedures and can often see specialists without lengthy delays. Americans with high-quality employer-sponsored coverage give their plans relatively high ratings.
Competition between providers can theoretically drive quality improvements, though this effect is often undermined by the complexity of the market and the difficulty consumers face in shopping for healthcare.
Disadvantages of the Current U.S. System
The most glaring problem is simple: The United States remains the only developed country without universal healthcare, and 30 million Americans remain uninsured despite gains under the Affordable Care Act, and many of these gains will soon be lost. Being uninsured in America isn’t just an inconvenience—it can be deadly. People delay care, skip medications, and avoid preventive screenings because of cost concerns.
The administrative complexity is staggering. Doctors spend enormous amounts of time dealing with insurance companies, prior authorizations, and billing disputes. Hospitals employ armies of billing specialists just to navigate the maze of different insurance plans, each with its own rules, formularies, and coverage determinations. U.S. administrative costs account for ~25% of all healthcare spending, among the highest in the world.
Medical bankruptcy is uniquely American. Even people with insurance can find themselves financially devastated by serious illness. High deductibles, surprise bills, and out-of-network charges create a minefield of potential financial catastrophe. Studies of U.S. bankruptcy filings over the past two decades have consistently found that medical bills and medical problems are a major factor in a large share of consumer bankruptcies. Recent summaries suggest that roughly two‑thirds of US personal bankruptcies involve medical expenses or illness-related income loss, and around 17% of adults with health care debt report declaring bankruptcy or losing a home because of that debt.
The system is also profoundly inequitable. Quality of care often depends more on your job, your income, and your zip code than on your medical needs. Out-of-pocket costs per capita have increased as compared to previous decades and the burden falls disproportionately on those least able to afford it.
What Europe Shows Us
The European experience demonstrates that there isn’t one “right” way to achieve universal coverage. The UK’s NHS, Germany’s sickness funds, and France’s hybrid system all manage to cover everyone at roughly half the per-capita cost of American healthcare. Universal Health Coverage exists in all European countries, with healthcare financing almost universally government managed, either directly through taxation or semi-directly through mandated and government-subsidized social health insurance.
They’ve accomplished this through various combinations of centralized negotiation of drug prices, global budgets for hospitals, strong primary care systems that serve as gatekeepers to more expensive specialist care, emphasis on preventive services, and regulation that prevents insurance companies from cherry-picking healthy patients.
Are these systems perfect? No. One of the major disadvantages of centralized healthcare systems is long wait lists to access non-urgent care, though Americans often wait as long or longer for routine primary care appointments as do patients in most universal-coverage countries. Many European countries are wrestling with funding challenges as populations age and expensive new treatments become available. But they’ve solved the fundamental problem that America hasn’t: they ensure everyone has access to healthcare without the risk of financial ruin.
The Path Forward?
The debate over healthcare in America often presents false choices. We don’t have to choose between Canadian-style single-payer and our current system—there are multiple models we could adapt. We could move toward a German-style system with heavily regulated non-profit insurers. We could create a robust public option that competes with private insurance. We could expand Medicare gradually by lowering the eligibility age over time.
What’s clear from international comparisons is that the status quo is unusually expensive and produces mediocre results. We’re paying premium prices for economy outcomes. Whether single-payer is the answer depends partly on your priorities. Do you value universal coverage and cost control more than unlimited choice? Are you willing to accept potentially longer wait times for non-urgent care in exchange for lower costs and universal access? How much do you trust government to manage a program this large?
These aren’t easy questions, and reasonable people disagree. But the evidence from Europe suggests that universal coverage at reasonable cost is achievable—it just requires us to make some choices about what we value most in a healthcare system.
Sources:
- Centers for Medicare & Medicaid Services National Health Expenditure Data: https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/historical
- Commonwealth Fund international comparisons: https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022
- Peterson-KFF Health System Tracker: https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
- Wikipedia overview of single-payer systems: https://en.wikipedia.org/wiki/Single-payer_healthcare
- Harvard Health discussion of single-payer: https://www.health.harvard.edu/blog/single-payer-healthcare-pluses-minuses-means-201606279835
- BMC study on administrative costs: Referenced in Wikipedia article on single-payer healthcare
- Fraser Institute wait times data: https://www.fraserinstitute.org/studies/waiting-your-turn-wait-times-for-health-care-in-canada-2024
- Healthcare systems comparison (European models): https://www.healthcare-now.org/euhealthcare/

















Supply-Side Economics and Trickle-Down: What Actually Happened?
By John Turley
On January 12, 2026
In Commentary, Politics
The Basic Question
You’ve probably heard politicians arguing about tax cuts—some promising they’ll supercharge the economy, others dismissing them as giveaways to the rich. These debates usually involve two terms that get thrown around like political footballs: “supply-side economics” and “trickle-down economics.” But what do these terms actually mean, and more importantly, do they work? After four decades of real-world experiments, we finally have enough data to answer that question.
Understanding Supply-Side Economics
Supply-side economics is a legitimate economic theory that emerged in the 1970s when the U.S. economy was struggling with both high inflation and high unemployment—a combination that traditional economic theories said shouldn’t happen. The core idea is straightforward: economic growth comes from producing more goods and services (the “supply” side), not just from boosting consumer demand.
The theory rests on three main pillars. First, lower taxes—the thinking is that if people and businesses keep more of their money, they’ll work harder, invest more, and create jobs. According to economist Arthur Laffer’s famous curve, there’s supposedly a sweet spot where lower tax rates can actually generate more government revenue because the economy grows so much. Second, less regulation removes government restrictions so businesses can innovate and operate more efficiently. Third, smart monetary policy keeps inflation in check while maintaining enough money in the economy to fuel growth.
All of this sounds reasonable in theory. After all, who wouldn’t work harder if they kept more of their paycheck?
The Political Rebranding: Enter “Trickle-Down”
Here’s where economic theory meets political messaging. “Trickle-down economics” isn’t an academic term—it’s essentially a catchphrase, and not a complimentary one. Critics use it to describe supply-side policies when those policies mainly benefit wealthy people and corporations. The idea behind the name: give tax breaks to rich people and big companies, and the benefits will eventually “trickle down” to everyone else through job creation, higher wages, and economic growth.
Here’s the interesting part: no economist actually calls their theory “trickle-down economics.” Even David Stockman, President Reagan’s own budget director, later admitted that “supply-side” was basically a rebranding of “trickle-down” to make tax cuts for the wealthy easier to sell politically. So while they’re not identical concepts, they’re two sides of the same coin.
The Reagan Revolution: Testing the Theory
Ronald Reagan became president in 1981 and implemented the biggest supply-side experiment in U.S. history. He slashed the top tax rate from 70% down to 50%, and eventually to just 28%, arguing this would unleash economic growth that would lift all boats.
The results were genuinely mixed. On one hand, the economy created about 20 million jobs during Reagan’s presidency, unemployment fell from 7.6% to 5.5%, and the economy grew by 26% over eight years. Those aren’t small achievements.
But the picture gets more complicated when you look deeper. The tax cuts didn’t pay for themselves as promised—they reduced government revenue by about 9% initially. Reagan had to backtrack and raise taxes multiple times in 1982, 1983, 1984, and 1987 to address the mounting deficit problem. Income inequality increased significantly during this period, and surprisingly, the poverty rate at the end of Reagan’s term was essentially the same as when he started. Perhaps most telling, government debt more than doubled as a percentage of the economy.
There’s another wrinkle worth mentioning: much of the economic recovery happened because Federal Reserve Chairman Paul Volcker had already broken the back of inflation through tight monetary policy before Reagan’s tax cuts took effect. Disentangling how much credit Reagan’s policies deserve versus Volcker’s groundwork is genuinely difficult.
The Pattern Repeats
The story didn’t end with Reagan. George W. Bush enacted major tax cuts in 2001 and 2003, especially benefiting wealthy Americans. The result? Economic growth remained sluggish, deficits ballooned, and income inequality continued its upward march.
Then there’s Bill Clinton—the plot twist in this story. In 1993, Clinton actually raised taxes on the wealthy, pushing the top rate from 31% back up to 39.6%. Conservative economists predicted economic disaster. Instead, the economy boomed with what was then the longest sustained growth period in U.S. history, creating 22.7 million jobs. Even more remarkably, the government ran a budget surplus for the first time in decades.
Donald Trump’s 2017 tax cuts, focused heavily on corporations, showed minimal wage growth for workers while generating significant stock buybacks that primarily benefited shareholders—and yes, larger deficits. Trump’s subsequent economic policies in his second term have been characterized by such volatility that reasonable long-term assessments remain difficult.
The Kansas Experiment: A Modern Test Case
At the state level, Kansas Governor Sam Brownback implemented one of the boldest modern experiments in supply-side policy between 2012 and 2017, dramatically slashing income taxes especially for businesses. Proponents called it a “real live experiment” that would demonstrate supply-side principles in action.
Instead of unleashing growth, Kansas faced severe budget shortfalls that forced cuts to education and infrastructure. Economic growth actually lagged behind neighboring states that didn’t implement such aggressive cuts, and the state legislature eventually reversed many of the tax reductions. This case has become a frequently cited cautionary tale for critics of supply-side policies.
What Does Half a Century of Data Show?
After 50 years of real-world experiments, researchers finally have enough data to move beyond political rhetoric. A comprehensive study analyzed tax policy changes across 18 developed countries over five decades, looking at what actually happened after major tax cuts for the wealthy.
The findings are remarkably consistent. Tax cuts for the rich reliably increase income inequality—no surprise there. But they show no significant effect on overall economic growth rates and no significant effect on unemployment. Perhaps most damaging to the theory, they don’t “pay for themselves” through increased growth. At best, about one-third of lost revenue gets recovered through expanded economic activity.
In simpler terms: when you cut taxes for wealthy people, wealthy people get wealthier. The promised broader benefits largely fail to materialize. The 2022 World Inequality Report reinforced these conclusions, finding that the world’s richest 10% continue capturing the vast majority of all economic gains, while the bottom half of the population holds just 2% of all wealth.
Why the Theory Doesn’t Match Reality
When you think about it logically, the disconnect makes sense. If you give a tax cut to someone who’s already wealthy, they’ll probably save or invest most of it—they were already buying what they wanted and needed. Their daily spending habits don’t change much. But if you give money to someone who’s struggling to pay bills or afford necessities, they’ll spend it immediately, directly stimulating economic activity.
Economists call this concept “marginal propensity to consume,” and it explains why giving tax breaks to working and middle-class people actually does more to boost the economy than supply-side cuts focused on the wealthy. A dollar in the hands of someone who needs to spend it has more immediate economic impact than a dollar added to an already-substantial investment portfolio.
The Bottom Line
After 40-plus years of repeated experiments, the pattern is clear. Supply-side policies and trickle-down approaches consistently increase deficits, widen inequality, and fail to significantly boost overall economic growth or create more jobs than alternative policies. Meanwhile, periods with higher taxes on the wealthy, like the Clinton years, saw strong growth, robust job creation, and balanced budgets.
The Nuance Worth Keeping
None of this means all tax cuts are bad or that high taxes are always good—economics is rarely that simple. The critical questions are: who receives the tax cuts, and what outcomes do you realistically expect? Targeted tax cuts for working families, small businesses, or specific industries facing genuine challenges can serve as effective policy tools. Child tax credits, research and development incentives, or relief for struggling sectors might accomplish specific goals.
But the evidence accumulated over four decades is clear: broad tax cuts focused primarily on the wealthy and large corporations don’t deliver the promised economic benefits for everyone else. The benefits don’t trickle down in any meaningful way.
You’ll keep hearing these arguments for years to come. Politicians will continue promising that tax cuts for businesses and the wealthy will boost the entire economy. Now you know what the actual evidence shows, and you can judge those promises accordingly.
Sources: